Safety Profiles of Adalimumab, Etanercept and Infliximab: a Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events

AuthID
P-009-B08
3
Author(s)
Alves, C
·
Batel Marques, F
Tipo de Documento
Article
Year published
2014
Publicado
in JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, ISSN: 0269-4727
Volume: 39, Número: 3, Páginas: 307-313 (7)
Indexing
Publication Identifiers
Pubmed: 24635532
SCOPUS: 2-s2.0-84899437013
Wos: WOS:000334679600013
Source Identifiers
ISSN: 0269-4727
Export Publication Metadata
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.